Structure–activity relationships of sugar-based peptidomimetics as modulators of amyloid β-peptide early oligomerization and fibrillization
Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1–42 being the most aggregative and neurotoxic amyloid peptide, we report herein the capacity of sugar-based pentapeptide analogs to modulate the Aβ1–42 aggregation process...
Saved in:
Published in | European journal of medicinal chemistry Vol. 86; pp. 752 - 758 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
ISSY-LES-MOULINEAUX
Elsevier Masson SAS
30.10.2014
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1–42 being the most aggregative and neurotoxic amyloid peptide, we report herein the capacity of sugar-based pentapeptide analogs to modulate the Aβ1–42 aggregation process using thioflavin fluorescence and transmission electron microscopy assays. The importance of the free hydroxyl groups of the sugar moiety, used as a β-breaker element, is confirmed since hydroxylated compounds inhibit the aggregation process while benzylated ones enhance it. Furthermore, the most effective molecules were also evaluated by a recently developed capillary electrophoresis method, providing in vitro monitoring of the crucial, very early stages of the self-assembly process. This technique allowed us to investigate the effect of these compounds on the small non-fibrillar Aβ1–42 oligomers suspected by several groups worldwide as highly neurotoxic. We clearly demonstrated that molecules delaying the aggregation can stabilize the monomeric peptide or promote the formation of soluble oligomeric species. In contrast, molecules that accelerate the aggregation can prevent the presence of small toxic oligomers.
[Display omitted]
•Structure–activity relationships of Sugar-based pentapeptide analogs.•Two hydrophobic dipeptides are linked to a d-glucopyranosyl scaffold.•The molecules delay or accelerate the kinetics of β-amyloid early oligomerization.•The early oligomerization is monitored by capillary electrophoresis. |
---|---|
AbstractList | Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1–42 being the most aggregative and neurotoxic amyloid peptide, we report herein the capacity of sugar-based pentapeptide analogs to modulate the Aβ1–42 aggregation process using thioflavin fluorescence and transmission electron microscopy assays. The importance of the free hydroxyl groups of the sugar moiety, used as a β-breaker element, is confirmed since hydroxylated compounds inhibit the aggregation process while benzylated ones enhance it. Furthermore, the most effective molecules were also evaluated by a recently developed capillary electrophoresis method, providing in vitro monitoring of the crucial, very early stages of the self-assembly process. This technique allowed us to investigate the effect of these compounds on the small non-fibrillar Aβ1–42 oligomers suspected by several groups worldwide as highly neurotoxic. We clearly demonstrated that molecules delaying the aggregation can stabilize the monomeric peptide or promote the formation of soluble oligomeric species. In contrast, molecules that accelerate the aggregation can prevent the presence of small toxic oligomers.
[Display omitted]
•Structure–activity relationships of Sugar-based pentapeptide analogs.•Two hydrophobic dipeptides are linked to a d-glucopyranosyl scaffold.•The molecules delay or accelerate the kinetics of β-amyloid early oligomerization.•The early oligomerization is monitored by capillary electrophoresis. Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1-42 being the most aggregative and neurotoxic amyloid peptide, we report herein the capacity of sugar-based pentapeptide analogs to modulate the Aβ1-42 aggregation process using thioflavin fluorescence and transmission electron microscopy assays. The importance of the free hydroxyl groups of the sugar moiety, used as a β-breaker element, is confirmed since hydroxylated compounds inhibit the aggregation process while benzylated ones enhance it. Furthermore, the most effective molecules were also evaluated by a recently developed capillary electrophoresis method, providing in vitro monitoring of the crucial, very early stages of the self-assembly process. This technique allowed us to investigate the effect of these compounds on the small non-fibrillar Aβ1-42 oligomers suspected by several groups worldwide as highly neurotoxic. We clearly demonstrated that molecules delaying the aggregation can stabilize the monomeric peptide or promote the formation of soluble oligomeric species. In contrast, molecules that accelerate the aggregation can prevent the presence of small toxic oligomers. Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid beta peptides. A beta(1-42) being the most aggregative and neurotoxic amyloid peptide, we report herein the capacity of sugar-based pentapeptide analogs to modulate the A beta(1-42) aggregation process using thioflavin fluorescence and transmission electron microscopy assays. The importance of the free hydroxyl groups of the sugar moiety, used as a beta-breaker element, is confirmed since hydroxylated compounds inhibit the aggregation process while benzylated ones enhance it. Furthermore, the most effective molecules were also evaluated by a recently developed capillary electrophoresis method, providing in vitro monitoring of the crucial, very early stages of the self-assembly process. This technique allowed us to investigate the effect of these compounds on the small non-fibrillar A beta(1-42) oligomers suspected by several groups worldwide as highly neurotoxic. We clearly demonstrated that molecules delaying the aggregation can stabilize the monomeric peptide or promote the formation of soluble oligomeric species. In contrast, molecules that accelerate the aggregation can prevent the presence of small toxic oligomers. (c) 2014 Elsevier Masson SAS. All rights reserved. : Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1-42 being the most aggregative and neurotoxic amyloid peptide, we report herein the capacity of sugar-based pentapeptide analogs to modulate the Aβ1-42 aggregation process using thioflavin fluorescence and transmission electron microscopy assays. The importance of the free hydroxyl groups of the sugar moiety, used as a β-breaker element, is confirmed since hydroxylated compounds inhibit the aggregation process while benzylated ones enhance it. Furthermore, the most effective molecules were also evaluated by a recently developed capillary electrophoresis method, providing in vitro monitoring of the crucial, very early stages of the self-assembly process. This technique allowed us to investigate the effect of these compounds on the small non-fibrillar Aβ1-42 oligomers suspected by several groups worldwide as highly neurotoxic. We clearly demonstrated that molecules delaying the aggregation can stabilize the monomeric peptide or promote the formation of soluble oligomeric species. In contrast, molecules that accelerate the aggregation can prevent the presence of small toxic oligomers. |
Author | Ongeri, Sandrine Lequin, Olivier Soulier, Jean-Louis Crousse, Benoît Brinet, Dimitri Taverna, Myriam Kaffy, Julia Khemtémourian, Lucie |
Author_xml | – sequence: 1 givenname: Julia surname: Kaffy fullname: Kaffy, Julia organization: Molécules Fluorées et Chimie Médicinale, BioCIS UMR-CNRS 8076, LabEx LERMIT, Université Paris-Sud, Faculté de Pharmacie, 5 Rue Jean-Baptiste Clément, 92296 Châtenay-Malabry Cedex, France – sequence: 2 givenname: Dimitri surname: Brinet fullname: Brinet, Dimitri organization: Molécules Fluorées et Chimie Médicinale, BioCIS UMR-CNRS 8076, LabEx LERMIT, Université Paris-Sud, Faculté de Pharmacie, 5 Rue Jean-Baptiste Clément, 92296 Châtenay-Malabry Cedex, France – sequence: 3 givenname: Jean-Louis surname: Soulier fullname: Soulier, Jean-Louis organization: Molécules Fluorées et Chimie Médicinale, BioCIS UMR-CNRS 8076, LabEx LERMIT, Université Paris-Sud, Faculté de Pharmacie, 5 Rue Jean-Baptiste Clément, 92296 Châtenay-Malabry Cedex, France – sequence: 4 givenname: Lucie surname: Khemtémourian fullname: Khemtémourian, Lucie organization: Sorbonne Universités – UPMC Univ Paris 06, Ecole Normale Supérieure – PSL Research University, CNRS UMR 7203 LBM, 4 Place Jussieu, 75252 Paris Cedex 05, France – sequence: 5 givenname: Olivier surname: Lequin fullname: Lequin, Olivier organization: Sorbonne Universités – UPMC Univ Paris 06, Ecole Normale Supérieure – PSL Research University, CNRS UMR 7203 LBM, 4 Place Jussieu, 75252 Paris Cedex 05, France – sequence: 6 givenname: Myriam surname: Taverna fullname: Taverna, Myriam organization: Protéines et Nanotechnologies en Sciences Séparatives, Institut Galien de Paris Sud, UMR-CNRS 8612, Université Paris-Sud, Faculté de Pharmacie, 5 Rue Jean-Baptiste Clément, 92296 Châtenay-Malabry Cedex, France – sequence: 7 givenname: Benoît surname: Crousse fullname: Crousse, Benoît organization: Molécules Fluorées et Chimie Médicinale, BioCIS UMR-CNRS 8076, LabEx LERMIT, Université Paris-Sud, Faculté de Pharmacie, 5 Rue Jean-Baptiste Clément, 92296 Châtenay-Malabry Cedex, France – sequence: 8 givenname: Sandrine surname: Ongeri fullname: Ongeri, Sandrine email: sandrine.ongeri@u-psud.fr organization: Molécules Fluorées et Chimie Médicinale, BioCIS UMR-CNRS 8076, LabEx LERMIT, Université Paris-Sud, Faculté de Pharmacie, 5 Rue Jean-Baptiste Clément, 92296 Châtenay-Malabry Cedex, France |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25238173$$D View this record in MEDLINE/PubMed https://hal.science/hal-01067196$$DView record in HAL |
BookMark | eNqNkc-O0zAQhy20iO0uvAFCviKU4D9JnFyQVhWwSJU4AGfLsSdbV0lc2U5X5cQT7GXfhAfhIXgS3Kb0iDhYY42-b6SZ3xW6GN0ICL2kJKeEVm83OWwG0OucEVrkpMkJp0_Qgoqqzjgriwu0IIzxrGS8uERXIWwIIWVFyDN0yVKzpoIv0MOX6CcdJw-_fzwqHe3Oxj320Kto3RjWdhuw63CY7pTPWhXA4C1sozVusANEqwNWAQ_OTMlw_girYd87a_Cvn9nMAgbl-z12vb1zA3j7_Tgdq9Hgzrbe9v2p9Rw97VQf4MWpXqNvH95_Xd5mq88fPy1vVpnmTRUzqGktGg2qBF6kVzHgpC2bRglRUyaMAKOLjrVEEda0tOgaIUCUFQCtdcP5NXo9z12rXm69HZTfS6esvL1ZyUOPUFIJ2lQ7mthiZrV3IXjozgIl8hCF3Mg5CnmIQpJGpiiS9mrWtlM7gDlLf2-fgDczcA-t64K2MGo4YyksXvC0TZ1-VZ3o-v_ppY3Hcy7dNMakvptVSBfdWfDypBvrQUdpnP33Kn8A6tTEDw |
CitedBy_id | crossref_primary_10_4155_fmc_2021_0109 crossref_primary_10_1016_j_ejmech_2014_11_039 crossref_primary_10_1042_EBC20220046 crossref_primary_10_3762_bjoc_13_276 crossref_primary_10_1002_anie_202309958 crossref_primary_10_1002_elps_201500329 crossref_primary_10_4155_fmc_2017_0026 crossref_primary_10_1002_bip_22670 crossref_primary_10_1016_j_bmc_2017_05_027 crossref_primary_10_1039_C5CC05264E crossref_primary_10_1016_j_ejmech_2014_10_004 crossref_primary_10_1021_acsnano_7b01662 crossref_primary_10_1016_j_cbpa_2019_07_008 crossref_primary_10_1021_acscombsci_6b00116 crossref_primary_10_1016_j_talanta_2016_12_011 crossref_primary_10_1021_acschemneuro_8b00341 crossref_primary_10_1002_ange_202309958 crossref_primary_10_1002_ejoc_201700010 crossref_primary_10_1002_pep2_24083 crossref_primary_10_1021_acsami_1c02356 crossref_primary_10_1021_acschemneuro_8b00185 crossref_primary_10_1002_cplu_201600550 crossref_primary_10_1002_tcr_202000103 crossref_primary_10_1021_acs_jmedchem_5b01629 |
Cites_doi | 10.4155/FMC.12.94 10.1038/nsmb.1799 10.1016/j.tetasy.2007.08.004 10.1074/jbc.M110.181313 10.1002/cmdc.200700140 10.1021/ar8000475 10.1016/j.drudis.2009.10.009 10.1021/ja107675n 10.1074/jbc.M201750200 10.1016/j.abb.2010.02.001 10.1371/journal.pone.0047261 10.1073/pnas.1218402110 10.1038/nm1782 10.1002/cbic.200900666 10.1073/pnas.0905127106 10.1073/pnas.0506723102 10.1021/ml4002908 10.1038/nrm2101 10.1002/cmdc.201100585 10.1021/bi802046n 10.1517/13543776.2013.772983 10.1021/bi700411k 10.1021/jp408579v 10.1126/science.1213151 10.1016/j.jmb.2011.12.062 10.1016/j.ejmech.2011.10.008 10.1074/jbc.M803159200 10.1038/nchembio.719 10.1016/j.jmb.2013.02.005 10.1126/science.1132814 10.1002/elps.200406062 10.1016/S0076-6879(99)09020-5 10.4155/fmc.12.94 10.1002/1521-3765(20021004)8:19<4365::AID-CHEM4365>3.0.CO;2-U 10.1002/elps.201400271 10.1038/461895a 10.2174/1874070701105010039 10.1002/1521-3773(20020118)41:2<230::AID-ANIE230>3.0.CO;2-L |
ContentType | Journal Article |
Copyright | 2014 Elsevier Masson SAS Copyright © 2014 Elsevier Masson SAS. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: 2014 Elsevier Masson SAS – notice: Copyright © 2014 Elsevier Masson SAS. All rights reserved. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | 1KM BLEPL DTL GNMZZ CGR CUY CVF ECM EIF NPM AAYXX CITATION 1XC |
DOI | 10.1016/j.ejmech.2014.09.031 |
DatabaseName | Index Chemicus Web of Science Core Collection Science Citation Index Expanded Web of Science - Science Citation Index Expanded - 2014 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Hyper Article en Ligne (HAL) |
DatabaseTitle | Web of Science MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE Web of Science |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1768-3254 |
EndPage | 758 |
ExternalDocumentID | oai_HAL_hal_01067196v1 10_1016_j_ejmech_2014_09_031 25238173 000343781800068 S0223523414008496 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Ministere de l'Enseignement Superieur et de la Recherche (MESR); Ministry of Research, France |
GroupedDBID | --- --K --M .~1 0R~ 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM 9JN AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AATCM AAXUO ABFRF ABGSF ABJNI ABMAC ABOCM ABUDA ABXDB ABYKQ ABZDS ACDAQ ACGFO ACIUM ACRLP ADBBV ADECG ADEZE ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AFZHZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FLBIZ FNPLU FYGXN G-Q GBLVA J1W KOM M2Y M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SES SPC SPCBC SSK SSP SSU SSZ T5K ~G- 1KM AAXKI AKRWK BLEPL DTL GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED CGR CUY CVF ECM EIF NPM 1B1 29G AAQXK AAYOK AAYXX ABFNM ACNNM ADMUD AFJKZ AGRDE ASPBG AVWKF AZFZN CITATION FEDTE FGOYB G-2 HMS HMT HVGLF HZ~ IHE R2- SCB SEW SOC SPT WUQ 1XC |
ID | FETCH-LOGICAL-c396t-e81879cea5e345e362e30b599a778127d7edc4f2b0a029b14f977e756ee18c933 |
IEDL.DBID | AIKHN |
ISICitedReferencesCount | 23 |
ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000343781800068 |
ISSN | 0223-5234 |
IngestDate | Tue Oct 15 15:48:08 EDT 2024 Thu Sep 26 18:17:27 EDT 2024 Sat Sep 28 08:15:34 EDT 2024 Fri Nov 01 20:18:21 EDT 2024 Wed Sep 18 05:37:37 EDT 2024 Fri Feb 23 02:29:18 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Oligomers Peptidomimetics Capillary electrophoresis Alzheimer's disease Glycopeptides Amyloid β-peptide DESIGN MIMETICS ACIDS STRATEGIES Amyloid beta-peptide INHIBITION SECONDARY NUCLEATION AGGREGATION |
Language | English |
License | Copyright © 2014 Elsevier Masson SAS. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
MergedId | FETCHMERGED-LOGICAL-c396t-e81879cea5e345e362e30b599a778127d7edc4f2b0a029b14f977e756ee18c933 |
ORCID | 0000-0002-2042-9942 0000-0002-2118-7324 0000-0003-4877-258X |
PMID | 25238173 |
PageCount | 7 |
ParticipantIDs | webofscience_primary_000343781800068 pubmed_primary_25238173 hal_primary_oai_HAL_hal_01067196v1 elsevier_sciencedirect_doi_10_1016_j_ejmech_2014_09_031 crossref_primary_10_1016_j_ejmech_2014_09_031 webofscience_primary_000343781800068CitationCount |
PublicationCentury | 2000 |
PublicationDate | 2014-10-30 |
PublicationDateYYYYMMDD | 2014-10-30 |
PublicationDate_xml | – month: 10 year: 2014 text: 2014-10-30 day: 30 |
PublicationDecade | 2010 |
PublicationPlace | ISSY-LES-MOULINEAUX |
PublicationPlace_xml | – name: ISSY-LES-MOULINEAUX – name: France |
PublicationTitle | European journal of medicinal chemistry |
PublicationTitleAbbrev | EUR J MED CHEM |
PublicationTitleAlternate | Eur J Med Chem |
PublicationYear | 2014 |
Publisher | Elsevier Masson SAS Elsevier |
Publisher_xml | – name: Elsevier Masson SAS – name: Elsevier |
References | Laganowsky, Liu, Sawaya, Whitelegge, Park, Zhao (bib7) 2012; 335 Reference 18. Härd, Lendel (bib16) 2012; 421 For a review, see Jan, Gokce, Luthi-Carter, Lashuel (bib11) 2008; 283 Yu, Edalji, Harlan, Holzman, Pereda Lopez, Labkovsky, Hillen, Barghorn, Ebert, Richardson, Miesbauer, Solomon, Bartley, Walter, Johnson, Hajduk, Olejniczak (bib8) 2009; 48 Butini, Brindisi, Brogi, Maramai, Guarino, Panico, Saxena, Chauhan, Colombo, Verga, De Lorenzi, Bartolini, Andrisano, Novellino, Campiani, Gemma (bib31) 2013; 4 Dorgeret, Khemtémourian, Correia, Soulier, Lequin, Ongeri (bib25) 2011; 46 Brinet, Kaffy, Oukacine, Glumm, Ongeri, Taverna (bib28) 2014 Cohen, Linse, Luheshi, Hellstrand, White, Rajah, Otzen, Vendruscolo, Dobson, Knowles (bib3) 2013; 110 Jeong, Ansaloni, Mezzenga, Lashuel, Dietler (bib5) 2013; 425 Smith, Cruz, Hochdörffer, März-Berberich, Nagel-Steger, Epple, Meyer-Zaika, Horn, Sticht, Sinha, Bitan, Schrader (bib29) 2013; 117 Ahmed, Davis, Aucoin, Sato, Ahuja, Aimoto, Elliott, Van Nostrand, Smith (bib9) 2010; 17 Dahlgren, Manelli, Blaine Stine, Baker, Krafft, LaDu (bib10) 2002; 277 LeVine (bib27) 1999; 309 Sabella, Quaglia, Lanni, Racchi, Govoni, Caccialanza, Calligaro, Bellotti, De Lorenzi (bib30) 2004; 25 Necula, Breydo, Milton, Rakez, van der Veer, Tone, Glabe (bib22) 2007; 46 Bieschke, Herbst, Wiglenda (bib21) 2012; 8 Vlieghe, Lisowski, Martinez, Khrestchatisky, Albericio, Kruger (bib24) 2010; 15 Ono, Condron, Teplow (bib12) 2009; 106 Cizas, Budvytyte, Morkuniene, Moldovan, Broccio, Lösche, Niaura, Valincius, Borutaite (bib15) 2010; 496 Belluti, Rampa, Gobbi, Bisi (bib20) 2013; 23 Matsumura, Shinoda, Yamada, Yokojima, Inoue, Ohnishi, Shimada, Kikuchi, Masui, Hashimoto, Sato, Ito, Akioka, Takagi, Nakamura, Nemoto, Hasegawa, Takamoto, Inoue, Nakamura, Nabeshima, Teplow, Kinjo, Hoshi (bib4) 2011; 286 Prangkio, Yusko, Sept, Yang, Mayer (bib14) 2012; 7 . Liu, Bitan (bib19) 2012; 7 Bartolini, Andrisano (bib17) 2010; 11 Gruner, Truffault, Voll, Locardi, Stöckle, Kessler, Schweizer, Risseueuw, Overhand, Fleet, Simone (bib26) 2002; 8 Lührs, Ritter, Adrian, Riek-Loher, Bohrmann, Döbeli, Schubert, Riek (bib6) 2005; 102 Goedert, Spillantini, Haas, Selkoe (bib2) 2006; 314 Stains, Mondal, Ghosh (bib18) 2007; 2 Shankar, Li, Mehta, Garcia-Munoz, Shepardson, Smith, Brett, Farrell, Rowan, Lemere, Regan, Walsh, Sabatini, Selkoe (bib13) 2008; 14 Cohen, SIA (WOS:000320930100045) 2013; 110 Takahashi, T (WOS:000260254300009) 2008; 41 Brinet, D. (000343781800068.6) 2014 Goedert, M (WOS:000241729800034) 2006; 314 Smith, MD (WOS:000328101100003) 2013; 117 Hochdorffer, K (WOS:000291715300041) 2011; 133 Neddenriep, Bradley (MEDLINE:24653784) 2011; 5 Laganowsky, A (WOS:000301225100046) 2012; 335 Bartolini, M (WOS:000278482200001) 2010; 11 Gruner, SAW (WOS:000178542000003) 2002; 8 Ahmed, M (WOS:000277330700008) 2010; 17 Yu, LP (WOS:000263896100004) 2009; 48 Shankar, GM (WOS:000258237500030) 2008; 14 Bieschke, J (WOS:000298414100017) 2012; 8 Jeong, JS (WOS:000319490100014) 2013; 425 Dorgeret, B (WOS:000297874300027) 2011; 46 Butini, S (WOS:000328529400014) 2013; 4 Schweizer, F (WOS:000173523400002) 2002; 41 Albericio, F (WOS:000308959400001) 2012; 4 Necula, M (WOS:000248229800016) 2007; 46 Vlieghe, P (WOS:000274085900006) 2010; 15 Risseeuw, MDP (WOS:000250607100001) 2007; 18 Liu, TY (WOS:000300942300003) 2012; 7 Luhrs, T (WOS:000233762000016) 2005; 102 Matsumura, S (WOS:000288797100065) 2011; 286 Jan, A (WOS:000259969300020) 2008; 283 Prangkio, P (WOS:000309995100083) 2012; 7 Cizas, P (WOS:000276757900003) 2010; 496 Ono, K (WOS:000269481000005) 2009; 106 LeVine, H (WOS:000084721400018) 1999; 309 Sabella, S (WOS:000224649500019) 2004; 25 Hard, T (WOS:000308383800003) 2012; 421 Haass, C (WOS:000243730300012) 2007; 8 Stains, CI (WOS:000251678000001) 2007; 2 Dahlgren, KN (WOS:000177718700093) 2002; 277 Belluti, F (WOS:000317936300004) 2013; 23 Laganowsky (10.1016/j.ejmech.2014.09.031_bib7) 2012; 335 Butini (10.1016/j.ejmech.2014.09.031_bib31) 2013; 4 10.1016/j.ejmech.2014.09.031_bib23a Bartolini (10.1016/j.ejmech.2014.09.031_bib17) 2010; 11 Jeong (10.1016/j.ejmech.2014.09.031_bib5) 2013; 425 Goedert (10.1016/j.ejmech.2014.09.031_bib2a) 2006; 314 Bieschke (10.1016/j.ejmech.2014.09.031_bib21) 2012; 8 Dahlgren (10.1016/j.ejmech.2014.09.031_bib10) 2002; 277 Smith (10.1016/j.ejmech.2014.09.031_bib29a) 2013; 117 Cizas (10.1016/j.ejmech.2014.09.031_bib15) 2010; 496 Schweizer (10.1016/j.ejmech.2014.09.031_bib26b) 2002; 41 Prangkio (10.1016/j.ejmech.2014.09.031_bib14) 2012; 7 Cohen (10.1016/j.ejmech.2014.09.031_bib3) 2013; 110 Takahashi (10.1016/j.ejmech.2014.09.031_bib23b) 2008; 41 Stains (10.1016/j.ejmech.2014.09.031_bib18) 2007; 2 Shankar (10.1016/j.ejmech.2014.09.031_bib13) 2008; 14 Yu (10.1016/j.ejmech.2014.09.031_bib8) 2009; 48 10.1016/j.ejmech.2014.09.031_oref1 Lührs (10.1016/j.ejmech.2014.09.031_bib6) 2005; 102 Härd (10.1016/j.ejmech.2014.09.031_bib16) 2012; 421 Sabella (10.1016/j.ejmech.2014.09.031_bib30) 2004; 25 Vlieghe (10.1016/j.ejmech.2014.09.031_bib24a) 2010; 15 Ahmed (10.1016/j.ejmech.2014.09.031_bib9) 2010; 17 Necula (10.1016/j.ejmech.2014.09.031_bib22) 2007; 46 Liu (10.1016/j.ejmech.2014.09.031_bib19) 2012; 7 Jan (10.1016/j.ejmech.2014.09.031_bib11) 2008; 283 Brinet (10.1016/j.ejmech.2014.09.031_bib28) 2014 Neddenriep (10.1016/j.ejmech.2014.09.031_bib23c) 2011; 5 LeVine (10.1016/j.ejmech.2014.09.031_bib27) 1999; 309 Dorgeret (10.1016/j.ejmech.2014.09.031_bib25) 2011; 46 Matsumura (10.1016/j.ejmech.2014.09.031_bib4) 2011; 286 Hochdörffer (10.1016/j.ejmech.2014.09.031_bib29b) 2011; 133 Haas (10.1016/j.ejmech.2014.09.031_bib2b) 2007; 8 10.1016/j.ejmech.2014.09.031_bib1a Belluti (10.1016/j.ejmech.2014.09.031_bib20) 2013; 23 Gruner (10.1016/j.ejmech.2014.09.031_bib26a) 2002; 8 Ono (10.1016/j.ejmech.2014.09.031_bib12) 2009; 106 Mucke (10.1016/j.ejmech.2014.09.031_bib1b) 2009; 461 Risseueuw (10.1016/j.ejmech.2014.09.031_bib26c) 2007; 18 Albericio (10.1016/j.ejmech.2014.09.031_bib24b) 2012; 4 |
References_xml | – volume: 496 start-page: 84 year: 2010 end-page: 92 ident: bib15 article-title: Size-dependent neurotoxicity of β-amyloid oligomers publication-title: Arch. Biochem. Biophys. contributor: fullname: Borutaite – volume: 335 start-page: 1228 year: 2012 end-page: 1231 ident: bib7 article-title: Atomic view of a toxic amyloid small oligomer publication-title: Science contributor: fullname: Zhao – year: 2014 ident: bib28 article-title: An improved CE method for the in vitro monitoring of the challenging early steps of the Aβ publication-title: Electrophoresis contributor: fullname: Taverna – volume: 4 start-page: 1178 year: 2013 end-page: 1182 ident: bib31 publication-title: ACS Med. Chem. Lett. contributor: fullname: Gemma – volume: 7 start-page: 359 year: 2012 end-page: 374 ident: bib19 article-title: Modulating self-assembly amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanism publication-title: ChemMedChem contributor: fullname: Bitan – volume: 425 start-page: 1765 year: 2013 end-page: 1781 ident: bib5 article-title: Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation publication-title: J. Mol. Biol. contributor: fullname: Dietler – volume: 283 start-page: 28176 year: 2008 end-page: 28189 ident: bib11 article-title: The ratio of monomeric to aggregated forms of Aβ40 and Aβ42 is an important determinant of amyloid-β aggregation, fibrillogenesis, and toxicity publication-title: J. Biol. Chem. contributor: fullname: Lashuel – volume: 8 start-page: 93 year: 2012 end-page: 101 ident: bib21 article-title: Small-molecule conversion of toxic oligomerts to nontoxic β-sheet-rich amyloid fibrils publication-title: Nat. Chem. Biol. contributor: fullname: Wiglenda – volume: 15 start-page: 40 year: 2010 end-page: 56 ident: bib24 article-title: Synthetic therapeutic peptides: science and market publication-title: Drug Discov. Today contributor: fullname: Kruger – volume: 110 start-page: 9758 year: 2013 end-page: 9763 ident: bib3 article-title: Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism publication-title: Proc. Natl. Acad. Sci. U. S. A. contributor: fullname: Knowles – volume: 117 start-page: 14907 year: 2013 end-page: 14915 ident: bib29 article-title: Changes to the structure and dynamics in mutations of Aβ publication-title: J. Phys. Chem. B contributor: fullname: Schrader – volume: 46 start-page: 8850 year: 2007 end-page: 8860 ident: bib22 article-title: Methylene blue inhibits amyloid Aβ oligomerization by promoting fibrillization publication-title: Biochemistry contributor: fullname: Glabe – volume: 277 start-page: 32046 year: 2002 end-page: 32053 ident: bib10 article-title: Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability publication-title: J. Biol. Chem. contributor: fullname: LaDu – volume: 421 start-page: 441 year: 2012 end-page: 465 ident: bib16 article-title: Inhibition of amyloid formation publication-title: J. Mol. Biol. contributor: fullname: Lendel – volume: 23 start-page: 581 year: 2013 end-page: 596 ident: bib20 article-title: Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010–2012) publication-title: Expert Opin. Ther. Pat. contributor: fullname: Bisi – volume: 8 start-page: 4366 year: 2002 end-page: 4376 ident: bib26 article-title: Design, synthesis, and NMR structure of linear and cyclic oligomers containing novel furanoid sugar amino acids publication-title: Chem. Eur. J. contributor: fullname: Simone – volume: 314 start-page: 777 year: 2006 end-page: 780 ident: bib2 article-title: A century of Alzheimer's disease publication-title: Science contributor: fullname: Selkoe – volume: 11 start-page: 1018 year: 2010 end-page: 1035 ident: bib17 article-title: Strategies for the inhibition of protein aggregation in human diseases publication-title: ChemBioChem contributor: fullname: Andrisano – volume: 7 start-page: e47261 year: 2012 ident: bib14 article-title: Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity publication-title: PLoS One contributor: fullname: Mayer – volume: 46 start-page: 5959 year: 2011 end-page: 5969 ident: bib25 article-title: Sugar-based peptidomimetics inhibit amyloid β-peptide aggregation publication-title: Eur. J. Med. Chem. contributor: fullname: Ongeri – volume: 106 start-page: 14745 year: 2009 end-page: 14750 ident: bib12 article-title: Structure–neurotoxicity relationships of amyloid β-protein oligomers publication-title: Proc. Natl. Acad. Sci. U. S. A. contributor: fullname: Teplow – volume: 286 start-page: 11555 year: 2011 end-page: 11562 ident: bib4 article-title: Two distinct amyloid β-protein (Aβ) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses publication-title: J. Biol. Chem. contributor: fullname: Hoshi – volume: 17 start-page: 561 year: 2010 end-page: 567 ident: bib9 article-title: Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils publication-title: Nat. Struct. Mol. Biol. contributor: fullname: Smith – volume: 2 start-page: 1674 year: 2007 end-page: 1692 ident: bib18 article-title: Molecules that target beta-amyloid publication-title: ChemMedChem contributor: fullname: Ghosh – volume: 309 start-page: 274 year: 1999 end-page: 284 ident: bib27 article-title: Quantification of β-sheet amyloid fibril structures with thioflavin T publication-title: Methods Enzymol. contributor: fullname: LeVine – volume: 48 start-page: 1870 year: 2009 end-page: 1877 ident: bib8 article-title: Structural characterization of a soluble amyloid β-peptide oligomer publication-title: Biochemistry contributor: fullname: Olejniczak – volume: 14 start-page: 837 year: 2008 end-page: 842 ident: bib13 article-title: Amyloid β-protein dimers isolated directly from Alzheimer brains impair synaptic plasticity and memory publication-title: Nat. Med. contributor: fullname: Selkoe – volume: 102 start-page: 17342 year: 2005 end-page: 17347 ident: bib6 article-title: 3D structure of Alzheimer's amyloid-β(1–42) fibrils publication-title: Proc. Natl. Acad. Sci. U. S. A. contributor: fullname: Riek – volume: 25 start-page: 3186 year: 2004 end-page: 3194 ident: bib30 article-title: Capillary electrophoresis studies on the aggregation process of β-amyloid 1–42 and 1–40 peptides publication-title: Electrophoresis contributor: fullname: De Lorenzi – volume: 5 start-page: 39 year: 2011 ident: MEDLINE:24653784 article-title: Short Peptides as Inhibitors of Amyloid Aggregation. publication-title: The open biotechnology journal contributor: fullname: Neddenriep, Bradley – year: 2014 ident: 000343781800068.6 article-title: An improved CE method for the in vitro monitoring of the challenging early steps of the Aβ1-42Peptide oligomerization: application to anti-Alzheimer's drug discovery publication-title: Electrophoresis contributor: fullname: Brinet, D. – volume: 4 start-page: 1527 year: 2012 ident: WOS:000308959400001 article-title: Therapeutic peptides FOREWORD publication-title: FUTURE MEDICINAL CHEMISTRY doi: 10.4155/FMC.12.94 contributor: fullname: Albericio, F – volume: 17 start-page: 561 year: 2010 ident: WOS:000277330700008 article-title: Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils publication-title: NATURE STRUCTURAL & MOLECULAR BIOLOGY doi: 10.1038/nsmb.1799 contributor: fullname: Ahmed, M – volume: 18 start-page: 2001 year: 2007 ident: WOS:000250607100001 article-title: A compendium of sugar amino acids (SAA): scaffolds, peptide- and glyco-mimetics publication-title: TETRAHEDRON-ASYMMETRY doi: 10.1016/j.tetasy.2007.08.004 contributor: fullname: Risseeuw, MDP – volume: 286 start-page: 11555 year: 2011 ident: WOS:000288797100065 article-title: Two Distinct Amyloid beta-Protein (A beta) Assembly Pathways Leading to Oligomers and Fibrils Identified by Combined Fluorescence Correlation Spectroscopy, Morphology, and Toxicity Analyses publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY doi: 10.1074/jbc.M110.181313 contributor: fullname: Matsumura, S – volume: 2 start-page: 1674 year: 2007 ident: WOS:000251678000001 article-title: Molecules that target beta-amyloid publication-title: CHEMMEDCHEM doi: 10.1002/cmdc.200700140 contributor: fullname: Stains, CI – volume: 41 start-page: 1309 year: 2008 ident: WOS:000260254300009 article-title: Peptide and Protein Mimetics Inhibiting Amyloid beta-Peptide Aggregation publication-title: ACCOUNTS OF CHEMICAL RESEARCH doi: 10.1021/ar8000475 contributor: fullname: Takahashi, T – volume: 15 start-page: 40 year: 2010 ident: WOS:000274085900006 article-title: Synthetic therapeutic peptides: science and market publication-title: DRUG DISCOVERY TODAY doi: 10.1016/j.drudis.2009.10.009 contributor: fullname: Vlieghe, P – volume: 133 start-page: 4348 year: 2011 ident: WOS:000291715300041 article-title: Rational Design of beta-Sheet Ligands Against A beta(42)-Induced Toxicity publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/ja107675n contributor: fullname: Hochdorffer, K – volume: 277 start-page: 32046 year: 2002 ident: WOS:000177718700093 article-title: Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY doi: 10.1074/jbc.M201750200 contributor: fullname: Dahlgren, KN – volume: 496 start-page: 84 year: 2010 ident: WOS:000276757900003 article-title: Size-dependent neurotoxicity of beta-amyloid oligomers publication-title: ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS doi: 10.1016/j.abb.2010.02.001 contributor: fullname: Cizas, P – volume: 7 start-page: ARTN e47261 year: 2012 ident: WOS:000309995100083 article-title: Multivariate Analyses of Amyloid-Beta Oligomer Populations Indicate a Connection between Pore Formation and Cytotoxicity publication-title: PLOS ONE doi: 10.1371/journal.pone.0047261 contributor: fullname: Prangkio, P – volume: 110 start-page: 9758 year: 2013 ident: WOS:000320930100045 article-title: Proliferation of amyloid-beta 42 aggregates occurs through a secondary nucleation mechanism publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA doi: 10.1073/pnas.1218402110 contributor: fullname: Cohen, SIA – volume: 14 start-page: 837 year: 2008 ident: WOS:000258237500030 article-title: Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory publication-title: NATURE MEDICINE doi: 10.1038/nm1782 contributor: fullname: Shankar, GM – volume: 41 start-page: 230 year: 2002 ident: WOS:000173523400002 article-title: Glycosamino acids: Building blocks for combinatorial synthesis - Implications for drug discovery publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION contributor: fullname: Schweizer, F – volume: 11 start-page: 1018 year: 2010 ident: WOS:000278482200001 article-title: Strategies for the Inhibition of Protein Aggregation in Human Diseases publication-title: CHEMBIOCHEM doi: 10.1002/cbic.200900666 contributor: fullname: Bartolini, M – volume: 106 start-page: 14745 year: 2009 ident: WOS:000269481000005 article-title: Structure-neurotoxicity relationships of amyloid beta-protein oligomers publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA doi: 10.1073/pnas.0905127106 contributor: fullname: Ono, K – volume: 102 start-page: 17342 year: 2005 ident: WOS:000233762000016 article-title: 3D structure of Alzheimer's amyloid-beta(1-42) fibrils publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA doi: 10.1073/pnas.0506723102 contributor: fullname: Luhrs, T – volume: 4 start-page: 1178 year: 2013 ident: WOS:000328529400014 article-title: Multifunctional Cholinesterase and Amyloid Beta Fibrillization Modulators. Synthesis and Biological Investigation publication-title: ACS MEDICINAL CHEMISTRY LETTERS doi: 10.1021/ml4002908 contributor: fullname: Butini, S – volume: 8 start-page: 101 year: 2007 ident: WOS:000243730300012 article-title: Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide publication-title: NATURE REVIEWS MOLECULAR CELL BIOLOGY doi: 10.1038/nrm2101 contributor: fullname: Haass, C – volume: 7 start-page: 359 year: 2012 ident: WOS:000300942300003 article-title: Modulating Self-Assembly of Amyloidogenic Proteins as a Therapeutic Approach for Neurodegenerative Diseases: Strategies and Mechanisms publication-title: CHEMMEDCHEM doi: 10.1002/cmdc.201100585 contributor: fullname: Liu, TY – volume: 48 start-page: 1870 year: 2009 ident: WOS:000263896100004 article-title: Structural Characterization of a Soluble Amyloid beta-Peptide Oligomer publication-title: BIOCHEMISTRY doi: 10.1021/bi802046n contributor: fullname: Yu, LP – volume: 23 start-page: 581 year: 2013 ident: WOS:000317936300004 article-title: Small-molecule inhibitors/modulators of amyloid-beta peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010-2012) publication-title: EXPERT OPINION ON THERAPEUTIC PATENTS doi: 10.1517/13543776.2013.772983 contributor: fullname: Belluti, F – volume: 46 start-page: 8850 year: 2007 ident: WOS:000248229800016 article-title: Methylene blue inhibits amyloid A beta oligomerization by promoting fibrillization publication-title: BIOCHEMISTRY doi: 10.1021/bi700411k contributor: fullname: Necula, M – volume: 117 start-page: 14907 year: 2013 ident: WOS:000328101100003 article-title: Changes to the Structure and Dynamics in Mutations of A beta(21-30) Caused by Ions in Solution publication-title: JOURNAL OF PHYSICAL CHEMISTRY B doi: 10.1021/jp408579v contributor: fullname: Smith, MD – volume: 8 start-page: 4366 year: 2002 ident: WOS:000178542000003 article-title: Design, synthesis, and NMR structure of linear and cyclic oligomers containing novel furanoid sugar amino acids publication-title: CHEMISTRY-A EUROPEAN JOURNAL contributor: fullname: Gruner, SAW – volume: 309 start-page: 274 year: 1999 ident: WOS:000084721400018 article-title: Quantification of beta-sheet amyloid fibril structures with thioflavin T publication-title: AMYLOID, PRIONS, AND OTHER PROTEIN AGGREGATES contributor: fullname: LeVine, H – volume: 335 start-page: 1228 year: 2012 ident: WOS:000301225100046 article-title: Atomic View of a Toxic Amyloid Small Oligomer publication-title: SCIENCE doi: 10.1126/science.1213151 contributor: fullname: Laganowsky, A – volume: 421 start-page: 441 year: 2012 ident: WOS:000308383800003 article-title: Inhibition of Amyloid Formation publication-title: JOURNAL OF MOLECULAR BIOLOGY doi: 10.1016/j.jmb.2011.12.062 contributor: fullname: Hard, T – volume: 46 start-page: 5959 year: 2011 ident: WOS:000297874300027 article-title: Sugar-based peptidomimetics inhibit amyloid beta-peptide aggregation publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2011.10.008 contributor: fullname: Dorgeret, B – volume: 283 start-page: 28176 year: 2008 ident: WOS:000259969300020 article-title: The ratio of monomeric to aggregated forms of A beta 40 and A beta 42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY doi: 10.1074/jbc.M803159200 contributor: fullname: Jan, A – volume: 8 start-page: 93 year: 2012 ident: WOS:000298414100017 article-title: Small-molecule conversion of toxic oligomers to nontoxic beta-sheet-rich amyloid fibrils publication-title: NATURE CHEMICAL BIOLOGY doi: 10.1038/nchembio.719 contributor: fullname: Bieschke, J – volume: 425 start-page: 1765 year: 2013 ident: WOS:000319490100014 article-title: Novel Mechanistic Insight into the Molecular Basis of Amyloid Polymorphism and Secondary Nucleation during Amyloid Formation publication-title: JOURNAL OF MOLECULAR BIOLOGY doi: 10.1016/j.jmb.2013.02.005 contributor: fullname: Jeong, JS – volume: 314 start-page: 777 year: 2006 ident: WOS:000241729800034 article-title: A century of Alzheimer's disease publication-title: SCIENCE doi: 10.1126/science.1132814 contributor: fullname: Goedert, M – volume: 25 start-page: 3186 year: 2004 ident: WOS:000224649500019 article-title: Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides publication-title: ELECTROPHORESIS doi: 10.1002/elps.200406062 contributor: fullname: Sabella, S – volume: 283 start-page: 28176 year: 2008 ident: 10.1016/j.ejmech.2014.09.031_bib11 article-title: The ratio of monomeric to aggregated forms of Aβ40 and Aβ42 is an important determinant of amyloid-β aggregation, fibrillogenesis, and toxicity publication-title: J. Biol. Chem. doi: 10.1074/jbc.M803159200 contributor: fullname: Jan – volume: 48 start-page: 1870 year: 2009 ident: 10.1016/j.ejmech.2014.09.031_bib8 article-title: Structural characterization of a soluble amyloid β-peptide oligomer publication-title: Biochemistry doi: 10.1021/bi802046n contributor: fullname: Yu – ident: 10.1016/j.ejmech.2014.09.031_oref1 – volume: 46 start-page: 5959 year: 2011 ident: 10.1016/j.ejmech.2014.09.031_bib25 article-title: Sugar-based peptidomimetics inhibit amyloid β-peptide aggregation publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2011.10.008 contributor: fullname: Dorgeret – volume: 110 start-page: 9758 year: 2013 ident: 10.1016/j.ejmech.2014.09.031_bib3 article-title: Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1218402110 contributor: fullname: Cohen – volume: 11 start-page: 1018 year: 2010 ident: 10.1016/j.ejmech.2014.09.031_bib17 article-title: Strategies for the inhibition of protein aggregation in human diseases publication-title: ChemBioChem doi: 10.1002/cbic.200900666 contributor: fullname: Bartolini – volume: 25 start-page: 3186 year: 2004 ident: 10.1016/j.ejmech.2014.09.031_bib30 article-title: Capillary electrophoresis studies on the aggregation process of β-amyloid 1–42 and 1–40 peptides publication-title: Electrophoresis doi: 10.1002/elps.200406062 contributor: fullname: Sabella – ident: 10.1016/j.ejmech.2014.09.031_bib1a – volume: 15 start-page: 40 year: 2010 ident: 10.1016/j.ejmech.2014.09.031_bib24a article-title: Synthetic therapeutic peptides: science and market publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2009.10.009 contributor: fullname: Vlieghe – volume: 309 start-page: 274 year: 1999 ident: 10.1016/j.ejmech.2014.09.031_bib27 article-title: Quantification of β-sheet amyloid fibril structures with thioflavin T publication-title: Methods Enzymol. doi: 10.1016/S0076-6879(99)09020-5 contributor: fullname: LeVine – volume: 7 start-page: 359 year: 2012 ident: 10.1016/j.ejmech.2014.09.031_bib19 article-title: Modulating self-assembly amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanism publication-title: ChemMedChem doi: 10.1002/cmdc.201100585 contributor: fullname: Liu – volume: 133 start-page: 4348 year: 2011 ident: 10.1016/j.ejmech.2014.09.031_bib29b article-title: Rational design of β-sheet ligands against Aβ42-induced toxicity publication-title: J. Am. Chem. Soc. doi: 10.1021/ja107675n contributor: fullname: Hochdörffer – volume: 286 start-page: 11555 year: 2011 ident: 10.1016/j.ejmech.2014.09.031_bib4 article-title: Two distinct amyloid β-protein (Aβ) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses publication-title: J. Biol. Chem. doi: 10.1074/jbc.M110.181313 contributor: fullname: Matsumura – volume: 4 start-page: 1527 year: 2012 ident: 10.1016/j.ejmech.2014.09.031_bib24b article-title: Therapeutic peptides publication-title: Future Med. Chem. doi: 10.4155/fmc.12.94 contributor: fullname: Albericio – volume: 4 start-page: 1178 year: 2013 ident: 10.1016/j.ejmech.2014.09.031_bib31 publication-title: ACS Med. Chem. Lett. doi: 10.1021/ml4002908 contributor: fullname: Butini – volume: 2 start-page: 1674 year: 2007 ident: 10.1016/j.ejmech.2014.09.031_bib18 article-title: Molecules that target beta-amyloid publication-title: ChemMedChem doi: 10.1002/cmdc.200700140 contributor: fullname: Stains – volume: 23 start-page: 581 year: 2013 ident: 10.1016/j.ejmech.2014.09.031_bib20 article-title: Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010–2012) publication-title: Expert Opin. Ther. Pat. doi: 10.1517/13543776.2013.772983 contributor: fullname: Belluti – ident: 10.1016/j.ejmech.2014.09.031_bib23a – volume: 46 start-page: 8850 year: 2007 ident: 10.1016/j.ejmech.2014.09.031_bib22 article-title: Methylene blue inhibits amyloid Aβ oligomerization by promoting fibrillization publication-title: Biochemistry doi: 10.1021/bi700411k contributor: fullname: Necula – volume: 8 start-page: 4366 year: 2002 ident: 10.1016/j.ejmech.2014.09.031_bib26a article-title: Design, synthesis, and NMR structure of linear and cyclic oligomers containing novel furanoid sugar amino acids publication-title: Chem. Eur. J. doi: 10.1002/1521-3765(20021004)8:19<4365::AID-CHEM4365>3.0.CO;2-U contributor: fullname: Gruner – volume: 14 start-page: 837 year: 2008 ident: 10.1016/j.ejmech.2014.09.031_bib13 article-title: Amyloid β-protein dimers isolated directly from Alzheimer brains impair synaptic plasticity and memory publication-title: Nat. Med. doi: 10.1038/nm1782 contributor: fullname: Shankar – volume: 335 start-page: 1228 year: 2012 ident: 10.1016/j.ejmech.2014.09.031_bib7 article-title: Atomic view of a toxic amyloid small oligomer publication-title: Science doi: 10.1126/science.1213151 contributor: fullname: Laganowsky – year: 2014 ident: 10.1016/j.ejmech.2014.09.031_bib28 article-title: An improved CE method for the in vitro monitoring of the challenging early steps of the Aβ1–42 peptide oligomerization: application to anti-Alzheimer's drug discovery publication-title: Electrophoresis doi: 10.1002/elps.201400271 contributor: fullname: Brinet – volume: 8 start-page: 93 year: 2012 ident: 10.1016/j.ejmech.2014.09.031_bib21 article-title: Small-molecule conversion of toxic oligomerts to nontoxic β-sheet-rich amyloid fibrils publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.719 contributor: fullname: Bieschke – volume: 8 start-page: 101 year: 2007 ident: 10.1016/j.ejmech.2014.09.031_bib2b article-title: Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer amyloid β-peptide publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm2101 contributor: fullname: Haas – volume: 102 start-page: 17342 year: 2005 ident: 10.1016/j.ejmech.2014.09.031_bib6 article-title: 3D structure of Alzheimer's amyloid-β(1–42) fibrils publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0506723102 contributor: fullname: Lührs – volume: 41 start-page: 1309 year: 2008 ident: 10.1016/j.ejmech.2014.09.031_bib23b article-title: Peptide and protein mimetics inhibiting amyloid peptide aggregation publication-title: Acc. Chem. Res. doi: 10.1021/ar8000475 contributor: fullname: Takahashi – volume: 117 start-page: 14907 year: 2013 ident: 10.1016/j.ejmech.2014.09.031_bib29a article-title: Changes to the structure and dynamics in mutations of Aβ21–30 caused by ions in solution publication-title: J. Phys. Chem. B doi: 10.1021/jp408579v contributor: fullname: Smith – volume: 277 start-page: 32046 year: 2002 ident: 10.1016/j.ejmech.2014.09.031_bib10 article-title: Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability publication-title: J. Biol. Chem. doi: 10.1074/jbc.M201750200 contributor: fullname: Dahlgren – volume: 18 start-page: 2001 year: 2007 ident: 10.1016/j.ejmech.2014.09.031_bib26c article-title: A compendium of sugar amino acids (SAA): scaffolds, peptide- and glyco-mimetics publication-title: Tetrahedron Asymmetry doi: 10.1016/j.tetasy.2007.08.004 contributor: fullname: Risseueuw – volume: 421 start-page: 441 year: 2012 ident: 10.1016/j.ejmech.2014.09.031_bib16 article-title: Inhibition of amyloid formation publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2011.12.062 contributor: fullname: Härd – volume: 496 start-page: 84 year: 2010 ident: 10.1016/j.ejmech.2014.09.031_bib15 article-title: Size-dependent neurotoxicity of β-amyloid oligomers publication-title: Arch. Biochem. Biophys. doi: 10.1016/j.abb.2010.02.001 contributor: fullname: Cizas – volume: 461 start-page: 895 year: 2009 ident: 10.1016/j.ejmech.2014.09.031_bib1b article-title: Alzheimers's disease publication-title: Nature doi: 10.1038/461895a contributor: fullname: Mucke – volume: 106 start-page: 14745 year: 2009 ident: 10.1016/j.ejmech.2014.09.031_bib12 article-title: Structure–neurotoxicity relationships of amyloid β-protein oligomers publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0905127106 contributor: fullname: Ono – volume: 17 start-page: 561 year: 2010 ident: 10.1016/j.ejmech.2014.09.031_bib9 article-title: Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils publication-title: Nat. Struct. Mol. Biol. doi: 10.1038/nsmb.1799 contributor: fullname: Ahmed – volume: 7 start-page: e47261 year: 2012 ident: 10.1016/j.ejmech.2014.09.031_bib14 article-title: Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity publication-title: PLoS One doi: 10.1371/journal.pone.0047261 contributor: fullname: Prangkio – volume: 5 start-page: 39 year: 2011 ident: 10.1016/j.ejmech.2014.09.031_bib23c article-title: Short peptides as inhibitors of amyloid aggregation publication-title: Open Biotechnol. J. doi: 10.2174/1874070701105010039 contributor: fullname: Neddenriep – volume: 425 start-page: 1765 year: 2013 ident: 10.1016/j.ejmech.2014.09.031_bib5 article-title: Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2013.02.005 contributor: fullname: Jeong – volume: 314 start-page: 777 year: 2006 ident: 10.1016/j.ejmech.2014.09.031_bib2a article-title: A century of Alzheimer's disease publication-title: Science doi: 10.1126/science.1132814 contributor: fullname: Goedert – volume: 41 start-page: 230 year: 2002 ident: 10.1016/j.ejmech.2014.09.031_bib26b article-title: Glycosamino acids: building blocks for combinatorial synthesis–implications for drug discovery publication-title: Angew. Chem. Int. Ed. doi: 10.1002/1521-3773(20020118)41:2<230::AID-ANIE230>3.0.CO;2-L contributor: fullname: Schweizer |
SSID | ssj0005600 |
Score | 2.2813416 |
Snippet | Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1–42 being the most aggregative and... Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid beta peptides. A beta(1-42) being the most... Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1-42 being the most aggregative and... : Alzheimer's disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides. Aβ1-42 being the most aggregative and... |
Source | Web of Science |
SourceID | hal crossref pubmed webofscience elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 752 |
SubjectTerms | Alzheimer's disease Amyloid beta-Peptides - chemistry Amyloid beta-Peptides - drug effects Amyloid β-peptide Capillary electrophoresis Carbohydrates - chemistry Chemical Sciences Chemistry, Medicinal Glycopeptides Life Sciences & Biomedicine Oligomers Oligopeptides - chemistry Oligopeptides - drug effects Organic chemistry Peptide Fragments - chemistry Peptide Fragments - drug effects Peptidomimetics Peptidomimetics - chemistry Peptidomimetics - pharmacology Pharmacology & Pharmacy Protein Multimerization - drug effects Science & Technology Structure-Activity Relationship |
Title | Structure–activity relationships of sugar-based peptidomimetics as modulators of amyloid β-peptide early oligomerization and fibrillization |
URI | https://dx.doi.org/10.1016/j.ejmech.2014.09.031 http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000343781800068 https://www.ncbi.nlm.nih.gov/pubmed/25238173 https://hal.science/hal-01067196 |
Volume | 86 |
WOS | 000343781800068 |
WOSCitedRecordID | wos000343781800068 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswEB3EzqG9FG26uUtAFEFOUS2JkhgeDaOBuwUBkgC5EZQ4ShRYlmE5BXwp-gW99E_6If2Ifkk5lGS3hy7oQQdRI2gZat4InPcGYM9YSNEhT53yoxdlAfd0jsaTfqQzaRE7N_Sj-P44mZxHby7iiy0Yd1wYKqtsY38T0120bkeG7dsczotieGrRx2YPNgpHJAovkx5su0WiPmyPXr-dHG8qPZKGiWLt6b8r6hh0rswLr0t0qxJBK3ga_A6heldUKvknnHKYdHQX7rTJJBs193sPtnC2A7fGXQ-3Hdg_aZSpVwfsbEO0qg_YPjvZaFav7sPnU6cje7PA75--ENeBWkqwRVcpd1XMa1blrL651AuPkM-wOdXDmKosSuJB1kzXrKwMdQOrFs5Yl6tpVRj27avX2CJDklNm1bS4rGilqKGAMj0zLCfqwXTaDj2A86NXZ-OJ17Zq8DIuk6WHh9S1PEMdI4_sloTI_TSWUgthUwhhBJosysPU134o0yDKbd6JIk4Qg8NMcv4Q-rNqho-B5bFI8zARmPg6SsNY-3FO-kuxSW12k-EAvM49at4ocqiuVO1aNe5U5E7lS2XdOQDR-VD9MrOUBY2_nPnCunx9ERLinozeKRpzyns2eH2wRo-aGbG2C2NKgwQfwN7PU2R93GkCcUEkeyLoDCD4F7NxK9lOUgXLJ__9TE_hNu059PWfQd9OLnxu06plugu9lx-D3fbj-QEY6CT5 |
link.rule.ids | 230,315,783,787,888,4511,24130,27938,27939,45599,45693 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV25bttAEB34KJwmSJzDyrkIDFcmxHu9pSDEkGNZMGAZcLdYcpc2DVEURNmAOn9BmvxJPiQfkS_JzJKUkiIHUrBZDkmJM5w3BOe9AdjXCCnKDxKr_OiEqRc4KjPaEW6oUoGInWl6UTwbxYPL8NNVdLUB_ZYLQ22VTe6vc7rN1s1Kt7mb3Vmedy8QfbB6wCwckii8iDdhG88tMNi3eyeng9G60yOumShoT-9dYcugs21e5rYw9quE1wieer9DqM0bapX8E05ZTDp-Ao-bYpL16t_7FDbMdBd2-u0Mt104OK-VqZeHbLwmWlWH7ICdrzWrl8_g84XVkb2bm-8PX4jrQCMl2LztlLvJZxUrM1bdXau5Q8in2Yz6YXRZ5AXxICumKlaUmqaBlXNrrIrlpMw1-_bVqW0NMySnzMpJfl3Sl6KaAsrUVLOMqAeTSbP0HC6PP477A6cZ1eCkgYgXjjmiqeWpUZEJQtxi3wRuEgmhOMcSgmtudBpmfuIq1xeJF2ZYdxoexcZ4R6kIghewNS2nZg9YFvEk82NuYleFiR8pN8pIfynSCVY3qemA07pHzmpFDtm2qt3K2p2S3CldIdGdHeCtD-UvkSURNP5y5Ad0-eoiJMQ96A0lrVnlPUxe92j0so6IlZ0fURnEgw7s_xwiq_1WEyjgRLIngk4HvH8x6zeS7SRVsHj13__pPewMxmdDOTwZnb6GR7THIrH7BrYw0MxbLLEWybvmEfoBSAMm9g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structure%E2%80%93activity+relationships+of+sugar-based+peptidomimetics+as+modulators+of+amyloid+%CE%B2-peptide+early+oligomerization+and+fibrillization&rft.jtitle=European+journal+of+medicinal+chemistry&rft.au=Kaffy%2C+Julia&rft.au=Brinet%2C+Dimitri&rft.au=Soulier%2C+Jean-Louis&rft.au=Khemt%C3%A9mourian%2C+Lucie&rft.date=2014-10-30&rft.pub=Elsevier+Masson+SAS&rft.issn=0223-5234&rft.eissn=1768-3254&rft.volume=86&rft.spage=752&rft.epage=758&rft_id=info:doi/10.1016%2Fj.ejmech.2014.09.031&rft.externalDocID=S0223523414008496 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0223-5234&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0223-5234&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0223-5234&client=summon |